Age-related macular degeneration (AMD) affects 12.7 million people in Europe and North America (Klein et al., 1995 Klein et al. 1999). As a combination of decreasing birth rate and increasing longevity alter the demographic of the population, the impact of this disease can only increase. This places an immense burden, not only on the individuals afflicted by the condition, but on the financial resources of society as a whole. Unfortunately, treatment for AMD is still very restricted, and even our understanding of the pathogenesis of the disease is far from complete One concern in tackling the growing problem of AMD is that methods used in the assessment of the condition are limited, usually based on fundus appearance and visual acuity. The ...
Age-related macular degeneration (AMD) is a leading cause of blindness and affects approximately one...
Age-related macular degeneration (AMD), the late stage of age-related maculopathy (ARM), is the lead...
© 2019 Dr. Rose RoseBackground Age-related macular degeneration (AMD) is a complex multifactorial d...
Age-related macular degeneration (AMD) affects 12.7 million people in Europe and North America (Klei...
Age-related maculopathy (ARM) is a central retinal disease with unclear pathogenesis. It is the majo...
With an ageing population, the number of age-related macular disease (ARMD) cases will inevitably ri...
With an ageing population, the number of age-related macular disease (ARMD) cases will inevitably ri...
PURPOSE. To evaluate the diagnostic potential of the electroretinogram (ERG) photostress test and th...
PURPOSE. To evaluate the diagnostic potential of the electroretinogram (ERG) photostress test and th...
PURPOSE. To evaluate the diagnostic potential of the electroretinogram (ERG) photostress test and th...
PURPOSE. To evaluate the diagnostic potential of the electroretinogram (ERG) photostress test and th...
Age-related Macular Degeneration (AMD) is a degenerative disorder that accounts for about 50% of bli...
Age-related macular degeneration (AMD) is predicted to affect 196 million people by 2020 (Wong et al...
Age-related macular degeneration (AMD) is predicted to affect 196 million people by 2020 (Wong et al...
Age-related macular degeneration (AMD) is predicted to affect 196 million people by 2020 (Wong et al...
Age-related macular degeneration (AMD) is a leading cause of blindness and affects approximately one...
Age-related macular degeneration (AMD), the late stage of age-related maculopathy (ARM), is the lead...
© 2019 Dr. Rose RoseBackground Age-related macular degeneration (AMD) is a complex multifactorial d...
Age-related macular degeneration (AMD) affects 12.7 million people in Europe and North America (Klei...
Age-related maculopathy (ARM) is a central retinal disease with unclear pathogenesis. It is the majo...
With an ageing population, the number of age-related macular disease (ARMD) cases will inevitably ri...
With an ageing population, the number of age-related macular disease (ARMD) cases will inevitably ri...
PURPOSE. To evaluate the diagnostic potential of the electroretinogram (ERG) photostress test and th...
PURPOSE. To evaluate the diagnostic potential of the electroretinogram (ERG) photostress test and th...
PURPOSE. To evaluate the diagnostic potential of the electroretinogram (ERG) photostress test and th...
PURPOSE. To evaluate the diagnostic potential of the electroretinogram (ERG) photostress test and th...
Age-related Macular Degeneration (AMD) is a degenerative disorder that accounts for about 50% of bli...
Age-related macular degeneration (AMD) is predicted to affect 196 million people by 2020 (Wong et al...
Age-related macular degeneration (AMD) is predicted to affect 196 million people by 2020 (Wong et al...
Age-related macular degeneration (AMD) is predicted to affect 196 million people by 2020 (Wong et al...
Age-related macular degeneration (AMD) is a leading cause of blindness and affects approximately one...
Age-related macular degeneration (AMD), the late stage of age-related maculopathy (ARM), is the lead...
© 2019 Dr. Rose RoseBackground Age-related macular degeneration (AMD) is a complex multifactorial d...